| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.deccanhealthcare.co.in | |
| Market Cap | 53.43 Cr. | |
| Enterprise Value(EV) | 50.77 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.18 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 146.78 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 41.99 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 45.60 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 0.57 | Calculated using Price: 26.22 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 2.04 Cr. | 20,376,180 Shares |
| FaceValue | 10 | |
| About Deccan Health Care Ltd. | ||
| The Company is engaged in developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products. The Company offers more than 1500 products. These products are used for various purposes such as hair care, skin care, heart care, immunity building etc. The Company offers a long-chain omerga-3 fatty acid, joint health nutrients, diacerein, antioxidants, immune enhancing components, skin ageing products, instant energy drinks, and calcium supplements; and a formula for males. The Company supplies their products in various forms such as tablets, capsules, gel, liquids, ointments, powder, pastes, etc. | ||
| 1 Day |
|
+4.82% |
| 1 Week |
|
+1.12% |
| 1 Month |
|
-6.51% |
| 3 Month |
|
-14.64% |
| 6 Month |
|
-15.19% |
| 1 Year |
|
-12.66% |
| 2 Year |
|
-29.33% |
| 5 Year |
|
-73.71% |
| 10 Year |
|
| 3 years | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0.51 | 0.42 | 0.46 | |
| Return on Capital Employed (%) | 0.81 | 0.89 | 0.78 | |
| Return on Assets (%) | 0.42 | 0.35 | 0.39 |
| Particulars | 4 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 77 | 77 | 82 | 82 | |
| Non Curr. Liab. | 3 | 3 | 3 | 3 | |
| Curr. Liab. | 13 | 10 | 12 | 17 | |
| Minority Int. | |||||
| Equity & Liab. | 92 | 91 | 97 | 102 | |
| Non Curr. Assets | 26 | 23 | 21 | 20 | |
| Curr. Assets | 66 | 68 | 76 | 82 | |
| Misc. Exp. not W/O | |||||
| Total Assets | 92 | 91 | 97 | 102 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 34 | 33 | 45 | |
| Other Income | 0 | 0 | 0 | |
| Total Income | 34 | 33 | 45 | |
| Total Expenditure | -32 | -28 | -43 | |
| PBIDT | 2 | 6 | 2 | |
| Interest | 0 | 0 | 0 | |
| Depreciation | -1 | -1 | -1 | |
| Taxation | 0 | 0 | 0 | |
| Exceptional Items | -3 | |||
| PAT | 0 | 0 | 0 | |
| Minority Interest | ||||
| Share Associate | ||||
| Other Related Items | ||||
| Consolidated Net Profit | 0 | 0 | 0 | |
| Adjusted EPS | 0 | 0 | 0 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | -1 | -7 | |
| Cash Fr. Inv. | 0 | 0 | 0 | |
| Cash Fr. Finan. | 0 | 0 | 5 | |
| Net Change | 0 | -1 | -1 | |
| Cash & Cash Eqvt | 3 | 3 | 1 |
|
Mon, 15 Apr 2024
Postal Ballot-Voting Results Postal Ballot-Voting Results with Scrutinizers Report |
|
Mon, 15 Apr 2024
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report Scrutinizers Report for the Postal Ballot |
|
Fri, 12 Apr 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot Proceedings of Postal Ballot. |
| Fri, 26 Apr 2024 |
Close Within 52 Week Low Zone
|
High Decrease in 1 Month
|
High Decrease in 3 Months
|
CCI Oversold Zone
|
RSI Oversold Zone
|
